• No results found

GnRH Antagonist (Elagolix)

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

ART Outcomes in GnRH Antagonist Protocol (Flexible) and Long GnRH Agonist Protocol during Early Follicular Phase in Patients with Polycystic Ovary Syndrome: A Randomized Clinical Trial

... with GnRH ago- nist ...in GnRH antagonist (flexible) group was higher than GnRH agonist group (5, 16, 17), but in GnRH antagonist during early and late follicular phase was lower ...

7

Effect of Pre-ovulatory Single Dose GnRH Agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study

Effect of Pre-ovulatory Single Dose GnRH Agonist Therapy on IVF Outcome in GnRH Antagonist Cycles; A Prospective Study

... of GnRH agonists if given during the luteal phase (10, ...pre-ovulatory GnRH agonists, it may be possible to displace the antagonists from the receptor site, thereby, leading to receptor activation (3) and ...

7

Original Article Larger leading follicle size on GnRH antagonist initiation day is associated with higher pregnancy rate in a flexible protocol for IVF/ICSI patients

Original Article Larger leading follicle size on GnRH antagonist initiation day is associated with higher pregnancy rate in a flexible protocol for IVF/ICSI patients

... (GnRH) antagonist protocol has been used in controlled ovarian hyper-stimulation (COH) for several years, but it is still unknown when the appropriate timing for antagonist admin- istration ...

8

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

... of GnRH analogues on oocyte morphology and quality remains ...the GnRH-ant group than in the GnRH-a group ...short GnRH-a protocols as com- pared with long-term ...the GnRH agonist and ...

10

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

GnRH Antagonist Protocol: Is It Effective for Expected Poor Ovarian Responders with Tubal Factor Undergoing IVF?

... of GnRH antagonists presented hope for POR. GnRH antagonists can induce pituitary suppression within a few hours without a “flare-up” effect, and the suppression can be released immediately after their ...

7

A STUDY ON THE EFFECTIVENESS OF CLOMIPHENE CITRATE IN COMPARISON TO GnRH ANTAGONIST IN PREVENTING LH SURGE AMONG PATIENTS UNDERGOING OVULATION INDUCTION IN IVF-ICSI

A STUDY ON THE EFFECTIVENESS OF CLOMIPHENE CITRATE IN COMPARISON TO GnRH ANTAGONIST IN PREVENTING LH SURGE AMONG PATIENTS UNDERGOING OVULATION INDUCTION IN IVF-ICSI

... (GnRH) antagonist or GnRH agonist in stimulated first fresh intracytoplasmic sperm injection cycle by evaluating the outcome of oocytes and em- bryo ...and GnRH antagonist plus ...

8

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols

Early-cleavage is a reliable predictor for embryo implantation in the GnRH agonist protocols but not in the GnRH antagonist protocols

... the GnRH agonist ...the GnRH antagonist group (Table 3). GnRH antagonists act through competi- tive binding to GnRH receptors, a situation that can be reversed by ...to GnRH ...

7

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisati

A three-arm randomised controlled trial comparing Gonadotrophin Releasing Hormone (GnRH) agonist long regimen versus GnRH agonist short regimen versus GnRH antagonist regimen in women with a history of poor ovarian response undergoing in vitro fertilisation (IVF) treatment: Poor responders intervention trial (PRINT)

... Treatment with this regimen starts on day 2 or 3 of the menstrual cycle. The woman will attend the ACU for a TVS and if the ovaries are quiescent and the endometrium thin (<5 mm) she will commence ovarian stimulation ...

9

Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study

Pregnancy outcome of “delayed start” GnRH antagonist protocol versus GnRH antagonist protocol in poor responders: A clinical trial study

... delayed-start GnRH antagonist protocol administered estrogen priming followed by early follicular-phase GnRH antagonist treatment for 7 days before ovarian stimulation with ...

8

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

Gonadotropin-Releasing Hormone (GnRH) Agonist Trigger in a GnRH Antagonist Protocol and Severe Ovarian Hyperstimulation Syndrome

... a GnRH antagonist protocol, followed by the cryopreservation of all oocytes/embryos (freeze-all strategy) ...in GnRH antagonist cycles is ~0% ...

5

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

GnRH antagonist rescue protocol combined with cabergoline versus cabergoline alone in the prevention of ovarian hyperstimulation syndrome: a randomized controlled trial

... stopped, GnRH agonist administration is continued and HCG administration is delayed until estradiol drops to a safe level (≤3000 pg/ ...18]. Antagonist rescue of agonist IVF cycles at risk of OHSS was first ...

8

A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles

A comparative study of GnRH antagonist and GnRH agonist in PCO patients undergoing IVF/ICSI cycles

... long GnRH analogue protocol. In antagonist group, HMG (150 IU/day) was started from third day of ...Then GnRH antagonist ...the GnRH antagonist may have more advantages such as ...

5

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

Switching from a gonadotropin releasing hormone (GnRH) agonist to a GnRH antagonist in prostate cancer patients: A systematic review and meta analysis

... Introduction: We sought to address whether there are clinical responses when patients who are failing gonadotropin releasing hormone (GnRH) agonist therapy are switched to degarelix. Androgen-deprivation therapy ...

16

GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles

GnRH Agonist and GnRH Antagonist in Intracytoplasmic Injection Cycles

... The limitation of the study was due to the retrospective nature of the analysis consisting of a medium size patient population with mixed infertility factors. All GnRH antagonist cycles were analysed as a ...

5

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article

GnRH agonist trigger versus hCG trigger in GnRH antagonist in IVF/ICSI cycles: A review article

... of GnRH agonist in in vitro fertilization (IVF) cycles are able to precede the final follicular maturation leading to removal of fertile oocyte with normal development of the embryo and ultimately ...using ...

10

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET)

... in GnRH-ant cycles, are still a matter of ...by GnRH-a administration is likely to be detrimental for the follicle- oocyte ...of antagonist were indeed associated with low implantation rates ...in ...

8

The aptness of antagonistic protocol in intracytoplasmic sperm injection: Embryologic study

The aptness of antagonistic protocol in intracytoplasmic sperm injection: Embryologic study

... that antagonist protocol is acceptable to program mainly for the patient with unfavorable prognoses ...of GnRH antagonist protocols have been proposed, reflecting the fact that the protocol is still ...

7

Download
			
			
				Download PDF

Download Download PDF

... Conclusion: Male contraceptive methods are still limited but hor- monal contraceptive methods are being developed. The basic mechanism of male hormonal contraception is to inhibit spermato- genesis by suppression of the ...

5

Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis

<p>Cardiovascular Risk Profile in Prostate Cancer Patients Treated with GnRH Agonists versus Antagonists: An Italian Real-World Analysis</p>

... for GnRH agonists, ATC code L02AE [buserelin (ATC code: L02AE01), leuprorelin (ATC code: L02AE02), goserelin (ATC code: L02AE03), triptor- elin (ATC code: L02AE04), histrelin (ATC code: L02AE05)] or GnRH ...

9

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome

Fixed versus Flexible Gonadotropin Releasing Hormone Antagonist Protocol in Controlled Ovarian Stimulation for Invitro Fertilization in Women with Polycystic Ovary Syndrome

... the GnRH antagonist protocol has been widely used around the world, it is not so popular in some infertility centers, that is mainly due to cost of the drug as well as the lack of practical experiences ...

6

Show all 1347 documents...

Related subjects